Topical carmustine (BCNU) in the treatment of mycosis fungoides

Dermatologic Therapy

Volumn 16, Issue 4, 2003, Pages 299-302

  Zackheim, Herschel S ^a  

^a Oncology Division   (United States)

Author keywords

bis chloroethyl nitrosourea (BCNU); Carmustine; Mycosis fungoides

Indexed keywords

CARMUSTINE; CORTICOSTEROID; EMOLLIENT AGENT;

ARTICLE; BURNING SENSATION; CLINICAL TRIAL; CRYOTHERAPY; DRUG EFFICACY; DRUG FORMULATION; DRUG POTENCY; DRUG STABILITY; DRUG TOLERABILITY; ERYTHEMA; FOLLOW UP; HEMATOLOGIC DISEASE; HUMAN; IRRITANT DERMATITIS; LEUKOPENIA; MYCOSIS FUNGOIDES; OINTMENT; SKIN ALLERGY; SKIN DISEASE; TELANGIECTASIA; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; CARMUSTINE; CLINICAL TRIALS; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MYCOSIS FUNGOIDES; NEOPLASM STAGING; RISK ASSESSMENT; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 0347990625     PISSN: 13960296     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1396-0296.2003.01641.x     Document Type: Article

References (5)

1. Fung MA, Murphy MJ, Hoss DM, Grant-Kels JM. Practical evaluation and management of cutaneous lymphoma. J Am Acad Dermatol 2002: 46: 325-357.
2. Zackheim HS. Treatment of mycosis fungoides with topical nitrosourea compounds. Arch Dermatol 1972: 106: 177-182.
3. Zackheim HS, Epstein EH, Jr, Crain WR. Topical carmustine (BCNU) for cutaneous T cell lymphoma: a 15-year experience in 143 patients. J Am Acad Dermatol 1990: 22: 802-810.
4. Ramsay DL, Meller JA, Zackheim HS. Topical treatment of early cutaneous T-cell lymphoma. Hematol/Oncol Clin North Am 1995: 9: 1031-1056.
5. Thomson KF, Sheehan-Dare RA, Wilkinson SM. Allergic dermatitis from topical carmustine. Contact Dermatitis 2000: 42: 112.